Advanced Medical Solutions Group (LON:AMS) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 211.09 ($2.72) and traded as high as GBX 229.50 ($2.96). Advanced Medical Solutions Group shares last traded at GBX 218.50 ($2.82), with a volume of 852,145 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 ($3.87) price objective on shares of Advanced Medical Solutions Group in a report on Wednesday, March 19th.

Advanced Medical Solutions Group Stock Performance

The company has a 50-day moving average of GBX 212.06 and a 200-day moving average of GBX 210.90. The firm has a market capitalization of £446.97 million, a P/E ratio of 40.11, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group (LON:AMS) last released its earnings results on Thursday, March 20th. The company reported GBX 10.65 ($0.14) EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. On average, equities analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current fiscal year.

Advanced Medical Solutions Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, June 20th. Stockholders of record on Thursday, May 29th will be given a dividend of GBX 1.83 ($0.02) per share. The ex-dividend date is Thursday, May 29th. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.77. This represents a dividend yield of 0.89%. Advanced Medical Solutions Group’s dividend payout ratio (DPR) is currently 38.76%.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.